nodes	percent_of_prediction	percent_of_DWPC	metapath
Azilsartan medoxomil—AGTR1—asthma	0.745	1	CbGaD
Azilsartan medoxomil—Tasosartan—AGTR2—asthma	0.00292	0.414	CrCbGaD
Azilsartan medoxomil—AGTR1—adrenal cortex—asthma	0.00119	0.164	CbGeAlD
Azilsartan medoxomil—AGTR1—epithelium—asthma	0.00119	0.163	CbGeAlD
Azilsartan medoxomil—AGTR1—smooth muscle tissue—asthma	0.00115	0.157	CbGeAlD
Azilsartan medoxomil—AGTR1—cardiovascular system—asthma	0.00109	0.15	CbGeAlD
Azilsartan medoxomil—AGTR1—trachea—asthma	0.00105	0.144	CbGeAlD
Azilsartan medoxomil—Tasosartan—AGTR1—asthma	0.00101	0.143	CrCbGaD
Azilsartan medoxomil—AGTR1—adrenal gland—asthma	0.000862	0.118	CbGeAlD
Azilsartan medoxomil—Olmesartan—AGTR1—asthma	0.000855	0.121	CrCbGaD
Azilsartan medoxomil—Telmisartan—AGTR1—asthma	0.000824	0.117	CrCbGaD
Azilsartan medoxomil—AGTR1—lung—asthma	0.000755	0.104	CbGeAlD
Azilsartan medoxomil—Candesartan—AGTR1—asthma	0.000665	0.0943	CrCbGaD
Azilsartan medoxomil—Diarrhoea—Zafirlukast—asthma	0.00045	0.00345	CcSEcCtD
Azilsartan medoxomil—Nausea—Indacaterol—asthma	0.000447	0.00344	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Aminophylline—asthma	0.000447	0.00343	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Loratadine—asthma	0.000446	0.00342	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—asthma	0.000445	0.00342	CcSEcCtD
Azilsartan medoxomil—Nausea—Orciprenaline—asthma	0.000444	0.00341	CcSEcCtD
Azilsartan medoxomil—Pruritus—Theophylline—asthma	0.000442	0.0034	CcSEcCtD
Azilsartan medoxomil—Rash—Fluticasone furoate—asthma	0.000441	0.00339	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Fluticasone furoate—asthma	0.000441	0.00338	CcSEcCtD
Azilsartan medoxomil—Oedema peripheral—Budesonide—asthma	0.00044	0.00338	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Budesonide—asthma	0.000438	0.00337	CcSEcCtD
Azilsartan medoxomil—Nausea—Nedocromil—asthma	0.000435	0.00334	CcSEcCtD
Azilsartan medoxomil—Dizziness—Zafirlukast—asthma	0.000434	0.00334	CcSEcCtD
Azilsartan medoxomil—Nausea—Pirbuterol—asthma	0.000432	0.00332	CcSEcCtD
Azilsartan medoxomil—Asthenia—Ciclesonide—asthma	0.000429	0.0033	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Ipratropium bromide—asthma	0.000429	0.00329	CcSEcCtD
Azilsartan medoxomil—Losartan—AGTR1—asthma	0.000428	0.0607	CrCbGaD
Azilsartan medoxomil—Fatigue—Ipratropium bromide—asthma	0.000428	0.00329	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Theophylline—asthma	0.000428	0.00329	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Loratadine—asthma	0.000422	0.00324	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Tiotropium—asthma	0.000421	0.00323	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Salbutamol—asthma	0.000418	0.00321	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Loratadine—asthma	0.000418	0.00321	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Tiotropium—asthma	0.000417	0.0032	CcSEcCtD
Azilsartan medoxomil—Nausea—Fluticasone furoate—asthma	0.000415	0.00319	CcSEcCtD
Azilsartan medoxomil—Rash—Zafirlukast—asthma	0.000414	0.00318	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Zafirlukast—asthma	0.000414	0.00318	CcSEcCtD
Azilsartan medoxomil—Dizziness—Theophylline—asthma	0.000413	0.00318	CcSEcCtD
Azilsartan medoxomil—Dizziness—Beclomethasone—asthma	0.000413	0.00318	CcSEcCtD
Azilsartan medoxomil—Fatigue—Salmeterol—asthma	0.000413	0.00317	CcSEcCtD
Azilsartan medoxomil—Angioedema—Mometasone—asthma	0.000413	0.00317	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Formoterol—asthma	0.000408	0.00314	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Arformoterol—asthma	0.000408	0.00314	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Budesonide—asthma	0.000405	0.00311	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Montelukast—asthma	0.0004	0.00307	CcSEcCtD
Azilsartan medoxomil—Dizziness—Ciclesonide—asthma	0.000396	0.00304	CcSEcCtD
Azilsartan medoxomil—Rash—Theophylline—asthma	0.000394	0.00303	CcSEcCtD
Azilsartan medoxomil—Rash—Beclomethasone—asthma	0.000394	0.00303	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Beclomethasone—asthma	0.000394	0.00302	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Theophylline—asthma	0.000394	0.00302	CcSEcCtD
Azilsartan medoxomil—Nausea—Zafirlukast—asthma	0.00039	0.003	CcSEcCtD
Azilsartan medoxomil—Asthenia—Cromoglicic acid—asthma	0.00039	0.003	CcSEcCtD
Azilsartan medoxomil—Angioedema—Formoterol—asthma	0.000388	0.00298	CcSEcCtD
Azilsartan medoxomil—Angioedema—Arformoterol—asthma	0.000388	0.00298	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Salbutamol—asthma	0.000386	0.00296	CcSEcCtD
Azilsartan medoxomil—Angioedema—Montelukast—asthma	0.00038	0.00292	CcSEcCtD
Azilsartan medoxomil—Rash—Ciclesonide—asthma	0.000377	0.0029	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Ciclesonide—asthma	0.000377	0.00289	CcSEcCtD
Azilsartan medoxomil—Muscle spasms—Budesonide—asthma	0.000373	0.00287	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Cromoglicic acid—asthma	0.000372	0.00286	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Loratadine—asthma	0.000371	0.00285	CcSEcCtD
Azilsartan medoxomil—Nausea—Theophylline—asthma	0.000371	0.00285	CcSEcCtD
Azilsartan medoxomil—Nausea—Beclomethasone—asthma	0.000371	0.00285	CcSEcCtD
Azilsartan medoxomil—Fatigue—Loratadine—asthma	0.000371	0.00285	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Tiotropium—asthma	0.000371	0.00285	CcSEcCtD
Azilsartan medoxomil—Angioedema—Salbutamol—asthma	0.000366	0.00281	CcSEcCtD
Azilsartan medoxomil—Dizziness—Cromoglicic acid—asthma	0.00036	0.00276	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—asthma	0.000359	0.00276	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Formoterol—asthma	0.000359	0.00276	CcSEcCtD
Azilsartan medoxomil—Asthenia—Ipratropium bromide—asthma	0.000356	0.00274	CcSEcCtD
Azilsartan medoxomil—Nausea—Ciclesonide—asthma	0.000355	0.00273	CcSEcCtD
Azilsartan medoxomil—Angioedema—Budesonide—asthma	0.000355	0.00273	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Montelukast—asthma	0.000352	0.0027	CcSEcCtD
Azilsartan medoxomil—Pruritus—Ipratropium bromide—asthma	0.000351	0.0027	CcSEcCtD
Azilsartan medoxomil—Asthenia—Salmeterol—asthma	0.000344	0.00264	CcSEcCtD
Azilsartan medoxomil—Fatigue—Flunisolide—asthma	0.000343	0.00264	CcSEcCtD
Azilsartan medoxomil—Rash—Cromoglicic acid—asthma	0.000343	0.00263	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Cromoglicic acid—asthma	0.000342	0.00263	CcSEcCtD
Azilsartan medoxomil—Pruritus—Fluticasone Propionate—asthma	0.00034	0.00261	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Formoterol—asthma	0.00034	0.00261	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Arformoterol—asthma	0.00034	0.00261	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Ipratropium bromide—asthma	0.00034	0.00261	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Formoterol—asthma	0.000337	0.00259	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Arformoterol—asthma	0.000337	0.00259	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Montelukast—asthma	0.000333	0.00256	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Montelukast—asthma	0.00033	0.00253	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Fluticasone Propionate—asthma	0.000329	0.00253	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Budesonide—asthma	0.000328	0.00252	CcSEcCtD
Azilsartan medoxomil—Dizziness—Ipratropium bromide—asthma	0.000328	0.00252	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Salmeterol—asthma	0.000328	0.00252	CcSEcCtD
Azilsartan medoxomil—Nausea—Cromoglicic acid—asthma	0.000323	0.00248	CcSEcCtD
Azilsartan medoxomil—Pruritus—Aminophylline—asthma	0.000322	0.00247	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Salbutamol—asthma	0.000321	0.00246	CcSEcCtD
Azilsartan medoxomil—Fatigue—Mometasone—asthma	0.000318	0.00244	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Salbutamol—asthma	0.000318	0.00244	CcSEcCtD
Azilsartan medoxomil—Dizziness—Fluticasone Propionate—asthma	0.000318	0.00244	CcSEcCtD
Azilsartan medoxomil—Dizziness—Salmeterol—asthma	0.000317	0.00244	CcSEcCtD
Azilsartan medoxomil—Rash—Ipratropium bromide—asthma	0.000313	0.0024	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Ipratropium bromide—asthma	0.000313	0.0024	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Aminophylline—asthma	0.000312	0.00239	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Budesonide—asthma	0.000311	0.00239	CcSEcCtD
Azilsartan medoxomil—Asthenia—Loratadine—asthma	0.000309	0.00237	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Budesonide—asthma	0.000308	0.00236	CcSEcCtD
Azilsartan medoxomil—Pruritus—Tiotropium—asthma	0.000304	0.00233	CcSEcCtD
Azilsartan medoxomil—Rash—Fluticasone Propionate—asthma	0.000303	0.00233	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Fluticasone Propionate—asthma	0.000303	0.00233	CcSEcCtD
Azilsartan medoxomil—Rash—Salmeterol—asthma	0.000302	0.00232	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Salmeterol—asthma	0.000302	0.00232	CcSEcCtD
Azilsartan medoxomil—Dizziness—Aminophylline—asthma	0.000301	0.00231	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Formoterol—asthma	0.000299	0.0023	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Arformoterol—asthma	0.000299	0.0023	CcSEcCtD
Azilsartan medoxomil—Fatigue—Arformoterol—asthma	0.000299	0.00229	CcSEcCtD
Azilsartan medoxomil—Fatigue—Formoterol—asthma	0.000299	0.00229	CcSEcCtD
Azilsartan medoxomil—Nausea—Ipratropium bromide—asthma	0.000295	0.00227	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Loratadine—asthma	0.000294	0.00226	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Montelukast—asthma	0.000293	0.00225	CcSEcCtD
Azilsartan medoxomil—Fatigue—Montelukast—asthma	0.000293	0.00225	CcSEcCtD
Azilsartan medoxomil—Rash—Aminophylline—asthma	0.000287	0.00221	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Aminophylline—asthma	0.000287	0.0022	CcSEcCtD
Azilsartan medoxomil—Asthenia—Flunisolide—asthma	0.000286	0.00219	CcSEcCtD
Azilsartan medoxomil—Nausea—Fluticasone Propionate—asthma	0.000286	0.00219	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IFNG—asthma	0.000285	0.00257	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Salmeterol—asthma	0.000285	0.00219	CcSEcCtD
Azilsartan medoxomil—Dizziness—Loratadine—asthma	0.000285	0.00218	CcSEcCtD
Azilsartan medoxomil—Dizziness—Tiotropium—asthma	0.000284	0.00218	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Salbutamol—asthma	0.000283	0.00217	CcSEcCtD
Azilsartan medoxomil—Fatigue—Salbutamol—asthma	0.000282	0.00217	CcSEcCtD
Azilsartan medoxomil—Pruritus—Flunisolide—asthma	0.000282	0.00216	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL10—asthma	0.00028	0.00253	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—EDNRB—asthma	0.00028	0.00252	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Budesonide—asthma	0.000274	0.0021	CcSEcCtD
Azilsartan medoxomil—Fatigue—Budesonide—asthma	0.000273	0.0021	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Flunisolide—asthma	0.000272	0.00209	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR3—asthma	0.000272	0.00245	CbGpPWpGaD
Azilsartan medoxomil—Rash—Loratadine—asthma	0.000271	0.00208	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Loratadine—asthma	0.000271	0.00208	CcSEcCtD
Azilsartan medoxomil—Rash—Tiotropium—asthma	0.000271	0.00208	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Tiotropium—asthma	0.000271	0.00208	CcSEcCtD
Azilsartan medoxomil—Nausea—Aminophylline—asthma	0.00027	0.00208	CcSEcCtD
Azilsartan medoxomil—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—asthma	0.000266	0.0024	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR3—asthma	0.000266	0.0024	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—CXCL8—asthma	0.000265	0.00239	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Mometasone—asthma	0.000265	0.00203	CcSEcCtD
Azilsartan medoxomil—Dizziness—Flunisolide—asthma	0.000263	0.00202	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—asthma	0.000261	0.00236	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Mometasone—asthma	0.000261	0.00201	CcSEcCtD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—ITPR1—asthma	0.000261	0.00235	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPY—asthma	0.000259	0.00234	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CYSLTR1—asthma	0.000258	0.00232	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Loratadine—asthma	0.000256	0.00196	CcSEcCtD
Azilsartan medoxomil—Nausea—Tiotropium—asthma	0.000255	0.00196	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL1B—asthma	0.000255	0.00229	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—IL2—asthma	0.000254	0.00228	CbGpPWpGaD
Azilsartan medoxomil—Connective tissue disorder—Hydrocortisone—asthma	0.000254	0.00195	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Mometasone—asthma	0.000253	0.00194	CcSEcCtD
Azilsartan medoxomil—Rash—Flunisolide—asthma	0.000251	0.00193	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Flunisolide—asthma	0.000251	0.00193	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—asthma	0.00025	0.00226	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—UTS2—asthma	0.000249	0.00224	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL11—asthma	0.000249	0.00224	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—C5AR1—asthma	0.000249	0.00224	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Formoterol—asthma	0.000249	0.00191	CcSEcCtD
Azilsartan medoxomil—Asthenia—Arformoterol—asthma	0.000249	0.00191	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—BDKRB2—asthma	0.000248	0.00224	CbGpPWpGaD
Azilsartan medoxomil—Losartan—ACE—asthma	0.000247	0.0351	CrCbGaD
Azilsartan medoxomil—AGTR1—G alpha (q) signalling events—EDN1—asthma	0.000246	0.00222	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Arformoterol—asthma	0.000245	0.00188	CcSEcCtD
Azilsartan medoxomil—Pruritus—Formoterol—asthma	0.000245	0.00188	CcSEcCtD
Azilsartan medoxomil—Asthenia—Montelukast—asthma	0.000244	0.00187	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—EDN1—asthma	0.000243	0.00219	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL5—asthma	0.000241	0.00218	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Montelukast—asthma	0.00024	0.00184	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDNRB—asthma	0.00024	0.00216	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR4—asthma	0.000238	0.00215	CbGpPWpGaD
Azilsartan medoxomil—Connective tissue disorder—Methylprednisolone—asthma	0.000238	0.00183	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—NPS—asthma	0.000237	0.00214	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—TAC1—asthma	0.000237	0.00214	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Arformoterol—asthma	0.000237	0.00182	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Formoterol—asthma	0.000237	0.00182	CcSEcCtD
Azilsartan medoxomil—Nausea—Flunisolide—asthma	0.000236	0.00182	CcSEcCtD
Azilsartan medoxomil—Asthenia—Salbutamol—asthma	0.000235	0.0018	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—C3AR1—asthma	0.000235	0.00211	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—ITPR1—asthma	0.000233	0.0021	CbGpPWpGaD
Azilsartan medoxomil—Rash—Mometasone—asthma	0.000233	0.00179	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—asthma	0.000233	0.0021	CbGpPWpGaD
Azilsartan medoxomil—Dermatitis—Mometasone—asthma	0.000233	0.00179	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Montelukast—asthma	0.000232	0.00178	CcSEcCtD
Azilsartan medoxomil—Pruritus—Salbutamol—asthma	0.000232	0.00178	CcSEcCtD
Azilsartan medoxomil—Dizziness—Formoterol—asthma	0.000229	0.00176	CcSEcCtD
Azilsartan medoxomil—Dizziness—Arformoterol—asthma	0.000229	0.00176	CcSEcCtD
Azilsartan medoxomil—Asthenia—Budesonide—asthma	0.000227	0.00175	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CYSLTR2—asthma	0.000226	0.00204	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Montelukast—asthma	0.000224	0.00172	CcSEcCtD
Azilsartan medoxomil—Pruritus—Budesonide—asthma	0.000224	0.00172	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Salbutamol—asthma	0.000224	0.00172	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—C5—asthma	0.000222	0.002	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—TACR1—asthma	0.000222	0.002	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—asthma	0.00022	0.00199	CbGpPWpGaD
Azilsartan medoxomil—Angiopathy—Methylprednisolone—asthma	0.00022	0.00169	CcSEcCtD
Azilsartan medoxomil—Nausea—Mometasone—asthma	0.000219	0.00168	CcSEcCtD
Azilsartan medoxomil—Rash—Formoterol—asthma	0.000219	0.00168	CcSEcCtD
Azilsartan medoxomil—Rash—Arformoterol—asthma	0.000219	0.00168	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Formoterol—asthma	0.000218	0.00168	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Arformoterol—asthma	0.000218	0.00168	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—LTB4R—asthma	0.000218	0.00197	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PTGDR—asthma	0.000218	0.00197	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCR5—asthma	0.000217	0.00196	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Budesonide—asthma	0.000217	0.00167	CcSEcCtD
Azilsartan medoxomil—Dizziness—Salbutamol—asthma	0.000216	0.00166	CcSEcCtD
Azilsartan medoxomil—AGTR1—Allograft Rejection—VEGFA—asthma	0.000215	0.00194	CbGpPWpGaD
Azilsartan medoxomil—Rash—Montelukast—asthma	0.000214	0.00164	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Montelukast—asthma	0.000214	0.00164	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—asthma	0.000213	0.00192	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—C3AR1—asthma	0.000213	0.00192	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—asthma	0.000213	0.00192	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—C3—asthma	0.000213	0.00192	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Prednisolone—asthma	0.00021	0.00161	CcSEcCtD
Azilsartan medoxomil—Dizziness—Budesonide—asthma	0.00021	0.00161	CcSEcCtD
Azilsartan medoxomil—Rash—Salbutamol—asthma	0.000206	0.00158	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Salbutamol—asthma	0.000206	0.00158	CcSEcCtD
Azilsartan medoxomil—Nausea—Arformoterol—asthma	0.000206	0.00158	CcSEcCtD
Azilsartan medoxomil—Nausea—Formoterol—asthma	0.000206	0.00158	CcSEcCtD
Azilsartan medoxomil—Angioedema—Hydrocortisone—asthma	0.000205	0.00158	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CYSLTR2—asthma	0.000205	0.00185	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR3—asthma	0.000203	0.00183	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Montelukast—asthma	0.000202	0.00155	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Betamethasone—asthma	0.0002	0.00154	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Dexamethasone—asthma	0.0002	0.00154	CcSEcCtD
Azilsartan medoxomil—Rash—Budesonide—asthma	0.0002	0.00153	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Budesonide—asthma	0.0002	0.00153	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—LTB4R—asthma	0.000198	0.00178	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PTGDR—asthma	0.000198	0.00178	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL22—asthma	0.000198	0.00178	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TGFB1—asthma	0.000198	0.00178	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—NPY—asthma	0.000198	0.00178	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Salbutamol—asthma	0.000194	0.00149	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—KNG1—asthma	0.000194	0.00174	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Triamcinolone—asthma	0.000193	0.00148	CcSEcCtD
Azilsartan medoxomil—Angioedema—Methylprednisolone—asthma	0.000193	0.00148	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—AGTR2—asthma	0.000191	0.00172	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	0.00019	0.00146	CcSEcCtD
Azilsartan medoxomil—Connective tissue disorder—Prednisone—asthma	0.000189	0.00145	CcSEcCtD
Azilsartan medoxomil—Nausea—Budesonide—asthma	0.000188	0.00145	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—asthma	0.000188	0.0017	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PMCH—asthma	0.000185	0.00167	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PTGDR2—asthma	0.000185	0.00167	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPSR1—asthma	0.000185	0.00167	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—HRH4—asthma	0.000185	0.00167	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Allograft Rejection—TNF—asthma	0.000185	0.00166	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—asthma	0.000183	0.00165	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—EDNRB—asthma	0.000183	0.00164	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CSF2RB—asthma	0.000181	0.00164	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—NPS—asthma	0.000181	0.00163	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—TAC1—asthma	0.000181	0.00163	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Hydrocortisone—asthma	0.00018	0.00138	CcSEcCtD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	0.000178	0.00137	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Hydrocortisone—asthma	0.000178	0.00137	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—TACR2—asthma	0.000178	0.0016	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR8—asthma	0.000178	0.0016	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCR3—asthma	0.000177	0.0016	CbGpPWpGaD
Azilsartan medoxomil—Angioedema—Betamethasone—asthma	0.000175	0.00135	CcSEcCtD
Azilsartan medoxomil—Angioedema—Dexamethasone—asthma	0.000175	0.00135	CcSEcCtD
Azilsartan medoxomil—Angiopathy—Prednisone—asthma	0.000174	0.00134	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—asthma	0.00017	0.00153	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—POMC—asthma	0.00017	0.00153	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Methylprednisolone—asthma	0.000169	0.0013	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PMCH—asthma	0.000168	0.00152	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—HRH4—asthma	0.000168	0.00152	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPSR1—asthma	0.000168	0.00152	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PTGDR2—asthma	0.000168	0.00152	CbGpPWpGaD
Azilsartan medoxomil—Skin disorder—Methylprednisolone—asthma	0.000167	0.00128	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CCL2—asthma	0.000166	0.0015	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CSF2RB—asthma	0.000165	0.00149	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	0.000163	0.00147	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—BDKRB2—asthma	0.000162	0.00146	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	0.000162	0.00146	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR8—asthma	0.000161	0.00145	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—TACR2—asthma	0.000161	0.00145	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL17—asthma	0.000158	0.00143	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Hydrocortisone—asthma	0.000158	0.00122	CcSEcCtD
Azilsartan medoxomil—Fatigue—Hydrocortisone—asthma	0.000158	0.00121	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PDE4A—asthma	0.000155	0.0014	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Dexamethasone—asthma	0.000154	0.00118	CcSEcCtD
Azilsartan medoxomil—Nervous system disorder—Betamethasone—asthma	0.000154	0.00118	CcSEcCtD
Azilsartan medoxomil—Angioedema—Prednisone—asthma	0.000153	0.00117	CcSEcCtD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6R—asthma	0.00015	0.00135	CbGpPWpGaD
Azilsartan medoxomil—Fatigue—Triamcinolone—asthma	0.000149	0.00114	CcSEcCtD
Azilsartan medoxomil—Fatigue—Methylprednisolone—asthma	0.000148	0.00114	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—KNG1—asthma	0.000147	0.00133	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	0.000146	0.00131	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CYSLTR1—asthma	0.000146	0.00131	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL10—asthma	0.000143	0.00129	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—asthma	0.000143	0.00128	CbGpPWpGaD
Azilsartan medoxomil—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	0.000141	0.00109	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PDE4A—asthma	0.000141	0.00127	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—UTS2—asthma	0.000141	0.00127	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—C5AR1—asthma	0.000141	0.00127	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—VIP—asthma	0.000141	0.00127	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—ADRB2—asthma	0.000139	0.00125	CbGpPWpGaD
Azilsartan medoxomil—Gastrointestinal disorder—Dexamethasone—asthma	0.000135	0.00104	CcSEcCtD
Azilsartan medoxomil—Gastrointestinal disorder—Betamethasone—asthma	0.000135	0.00104	CcSEcCtD
Azilsartan medoxomil—Fatigue—Dexamethasone—asthma	0.000135	0.00104	CcSEcCtD
Azilsartan medoxomil—Fatigue—Betamethasone—asthma	0.000135	0.00104	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR4—asthma	0.000135	0.00121	CbGpPWpGaD
Azilsartan medoxomil—Nervous system disorder—Prednisone—asthma	0.000134	0.00103	CcSEcCtD
Azilsartan medoxomil—Skin disorder—Prednisone—asthma	0.000132	0.00102	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CYSLTR1—asthma	0.000132	0.00119	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Hydrocortisone—asthma	0.000132	0.00101	CcSEcCtD
Azilsartan medoxomil—AGTR1—Peptide ligand-binding receptors—CXCL8—asthma	0.000131	0.00118	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL2RB—asthma	0.00013	0.00117	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Hydrocortisone—asthma	0.00013	0.000996	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PDE4D—asthma	0.000129	0.00116	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—VIP—asthma	0.000128	0.00115	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—C5AR1—asthma	0.000128	0.00115	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—UTS2—asthma	0.000128	0.00115	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL11—asthma	0.000128	0.00115	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—C3AR1—asthma	0.000126	0.00113	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FCER2—asthma	0.000126	0.00113	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Hydrocortisone—asthma	0.000125	0.000963	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—PDE4B—asthma	0.000125	0.00113	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—C5—asthma	0.000125	0.00113	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—TACR1—asthma	0.000125	0.00113	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—EDN1—asthma	0.000124	0.00112	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Prednisolone—asthma	0.000124	0.000953	CcSEcCtD
Azilsartan medoxomil—Asthenia—Triamcinolone—asthma	0.000124	0.000951	CcSEcCtD
Azilsartan medoxomil—Asthenia—Methylprednisolone—asthma	0.000124	0.000949	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL5—asthma	0.000123	0.00111	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR4—asthma	0.000122	0.0011	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Triamcinolone—asthma	0.000122	0.000938	CcSEcCtD
Azilsartan medoxomil—Pruritus—Methylprednisolone—asthma	0.000122	0.000936	CcSEcCtD
Azilsartan medoxomil—Dizziness—Hydrocortisone—asthma	0.000121	0.000931	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CYSLTR2—asthma	0.000121	0.00109	CbGpPWpGaD
Azilsartan medoxomil—Rash—Prednisolone—asthma	0.000118	0.000909	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Prednisolone—asthma	0.000118	0.000908	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Methylprednisolone—asthma	0.000118	0.000905	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL2RB—asthma	0.000118	0.00106	CbGpPWpGaD
Azilsartan medoxomil—Fatigue—Prednisone—asthma	0.000118	0.000903	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL22—asthma	0.000117	0.00105	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTGDR—asthma	0.000117	0.00105	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LTB4R—asthma	0.000117	0.00105	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PDE4D—asthma	0.000117	0.00105	CbGpPWpGaD
Azilsartan medoxomil—Rash—Hydrocortisone—asthma	0.000116	0.000888	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Hydrocortisone—asthma	0.000115	0.000887	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR3—asthma	0.000115	0.00103	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Triamcinolone—asthma	0.000114	0.000877	CcSEcCtD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	0.000114	0.00103	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Methylprednisolone—asthma	0.000114	0.000875	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—C5—asthma	0.000114	0.00103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PDE4B—asthma	0.000114	0.00103	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—TACR1—asthma	0.000114	0.00103	CbGpPWpGaD
Azilsartan medoxomil—Asthenia—Betamethasone—asthma	0.000112	0.000863	CcSEcCtD
Azilsartan medoxomil—Asthenia—Dexamethasone—asthma	0.000112	0.000863	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPY—asthma	0.000112	0.00101	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	0.000112	0.00101	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Prednisolone—asthma	0.000111	0.000856	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCR5—asthma	0.000111	0.001	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Dexamethasone—asthma	0.000111	0.000851	CcSEcCtD
Azilsartan medoxomil—Pruritus—Betamethasone—asthma	0.000111	0.000851	CcSEcCtD
Azilsartan medoxomil—Nausea—Hydrocortisone—asthma	0.000109	0.000836	CcSEcCtD
Azilsartan medoxomil—Rash—Triamcinolone—asthma	0.000109	0.000836	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Triamcinolone—asthma	0.000109	0.000835	CcSEcCtD
Azilsartan medoxomil—Rash—Methylprednisolone—asthma	0.000109	0.000834	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—C3—asthma	0.000109	0.000978	CbGpPWpGaD
Azilsartan medoxomil—Dermatitis—Methylprednisolone—asthma	0.000108	0.000833	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—AGTR2—asthma	0.000108	0.000971	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Betamethasone—asthma	0.000107	0.000823	CcSEcCtD
Azilsartan medoxomil—Diarrhoea—Dexamethasone—asthma	0.000107	0.000823	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR3—asthma	0.000104	0.000938	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Betamethasone—asthma	0.000104	0.000795	CcSEcCtD
Azilsartan medoxomil—Dizziness—Dexamethasone—asthma	0.000104	0.000795	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—EDNRB—asthma	0.000103	0.00093	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Triamcinolone—asthma	0.000103	0.000787	CcSEcCtD
Azilsartan medoxomil—Nausea—Methylprednisolone—asthma	0.000102	0.000786	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—TAC1—asthma	0.000102	0.00092	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—NPS—asthma	0.000102	0.00092	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPY—asthma	0.000101	0.000914	CbGpPWpGaD
Azilsartan medoxomil—Losartan—ALB—asthma	0.000101	0.0144	CrCbGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCR3—asthma	0.0001	0.000902	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPSR1—asthma	9.95e-05	0.000896	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTGDR2—asthma	9.95e-05	0.000896	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PMCH—asthma	9.95e-05	0.000896	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—HRH4—asthma	9.95e-05	0.000896	CbGpPWpGaD
Azilsartan medoxomil—Rash—Dexamethasone—asthma	9.88e-05	0.000758	CcSEcCtD
Azilsartan medoxomil—Rash—Betamethasone—asthma	9.88e-05	0.000758	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Dexamethasone—asthma	9.87e-05	0.000758	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Betamethasone—asthma	9.87e-05	0.000758	CcSEcCtD
Azilsartan medoxomil—Asthenia—Prednisone—asthma	9.79e-05	0.000752	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—AGTR2—asthma	9.78e-05	0.000882	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CSF2RB—asthma	9.74e-05	0.000877	CbGpPWpGaD
Azilsartan medoxomil—Pruritus—Prednisone—asthma	9.65e-05	0.000741	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TACR2—asthma	9.54e-05	0.000859	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR8—asthma	9.54e-05	0.000859	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL5—asthma	9.49e-05	0.000855	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—EDNRB—asthma	9.37e-05	0.000844	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL17—asthma	9.35e-05	0.000843	CbGpPWpGaD
Azilsartan medoxomil—Diarrhoea—Prednisone—asthma	9.33e-05	0.000717	CcSEcCtD
Azilsartan medoxomil—Nausea—Dexamethasone—asthma	9.3e-05	0.000714	CcSEcCtD
Azilsartan medoxomil—Nausea—Betamethasone—asthma	9.3e-05	0.000714	CcSEcCtD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—NPS—asthma	9.27e-05	0.000836	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—TAC1—asthma	9.27e-05	0.000836	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—BDKRB2—asthma	9.16e-05	0.000825	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCR3—asthma	9.09e-05	0.00082	CbGpPWpGaD
Azilsartan medoxomil—Dizziness—Prednisone—asthma	9.02e-05	0.000693	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADCY2—asthma	8.86e-05	0.000799	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL3—asthma	8.83e-05	0.000796	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	8.82e-05	0.000795	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	8.71e-05	0.000784	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—POMC—asthma	8.68e-05	0.000782	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL5—asthma	8.62e-05	0.000777	CbGpPWpGaD
Azilsartan medoxomil—Rash—Prednisone—asthma	8.6e-05	0.00066	CcSEcCtD
Azilsartan medoxomil—Dermatitis—Prednisone—asthma	8.59e-05	0.00066	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CCL2—asthma	8.49e-05	0.000765	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KIF3A—asthma	8.34e-05	0.000751	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PDE4A—asthma	8.34e-05	0.000751	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—KNG1—asthma	8.33e-05	0.000751	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—BDKRB2—asthma	8.32e-05	0.00075	CbGpPWpGaD
Azilsartan medoxomil—Nausea—Prednisone—asthma	8.1e-05	0.000622	CcSEcCtD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL10—asthma	8.09e-05	0.000729	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADCY2—asthma	8.05e-05	0.000725	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL3—asthma	8.02e-05	0.000723	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ADRB2—asthma	7.86e-05	0.000708	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CYSLTR1—asthma	7.81e-05	0.000703	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—KNG1—asthma	7.57e-05	0.000682	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CMA1—asthma	7.54e-05	0.000679	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—C5AR1—asthma	7.54e-05	0.000679	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—UTS2—asthma	7.54e-05	0.000679	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL11—asthma	7.54e-05	0.000679	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—VIP—asthma	7.54e-05	0.000679	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—ITPR1—asthma	7.43e-05	0.00067	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL10—asthma	7.35e-05	0.000662	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR4—asthma	7.23e-05	0.000651	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ADRB2—asthma	7.14e-05	0.000643	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—STAT6—asthma	7.09e-05	0.000639	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—EDN1—asthma	7.02e-05	0.000633	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCL5—asthma	6.97e-05	0.000628	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL2RB—asthma	6.96e-05	0.000627	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PDE4D—asthma	6.9e-05	0.000621	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CSF2—asthma	6.86e-05	0.000619	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—ITPR1—asthma	6.75e-05	0.000608	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PDE4B—asthma	6.72e-05	0.000606	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—C5—asthma	6.72e-05	0.000606	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TACR1—asthma	6.72e-05	0.000606	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR ligand binding—CXCL8—asthma	6.72e-05	0.000605	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	6.69e-05	0.000603	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—EDN1—asthma	6.38e-05	0.000575	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL5—asthma	6.33e-05	0.00057	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PLA2G4A—asthma	6.3e-05	0.000568	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CCR5—asthma	6.28e-05	0.000566	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CSF2—asthma	6.23e-05	0.000562	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL2RA—asthma	6.19e-05	0.000558	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR3—asthma	6.15e-05	0.000554	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—C3—asthma	6.13e-05	0.000553	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPY—asthma	5.99e-05	0.00054	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—PPP2CA—asthma	5.81e-05	0.000523	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—AGTR2—asthma	5.78e-05	0.000521	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCR5—asthma	5.7e-05	0.000514	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL2RA—asthma	5.62e-05	0.000506	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—C3—asthma	5.57e-05	0.000502	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—EDNRB—asthma	5.53e-05	0.000499	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TAC1—asthma	5.48e-05	0.000494	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NPS—asthma	5.48e-05	0.000494	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCR3—asthma	5.37e-05	0.000484	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CYBA—asthma	5.2e-05	0.000469	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PARP1—asthma	5.09e-05	0.000459	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL5—asthma	5.09e-05	0.000459	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—BDKRB2—asthma	4.91e-05	0.000443	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—POMC—asthma	4.91e-05	0.000442	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADCY2—asthma	4.75e-05	0.000428	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL3—asthma	4.74e-05	0.000427	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—KNG1—asthma	4.47e-05	0.000403	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—POMC—asthma	4.46e-05	0.000401	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CCL2—asthma	4.36e-05	0.000393	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6R—asthma	4.35e-05	0.000392	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL10—asthma	4.34e-05	0.000391	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—RHOA—asthma	4.32e-05	0.00039	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NTRK1—asthma	4.26e-05	0.000384	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ADRB2—asthma	4.22e-05	0.00038	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—ITPR1—asthma	3.99e-05	0.000359	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—RHOA—asthma	3.93e-05	0.000354	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CD86—asthma	3.8e-05	0.000342	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—CXCL8—asthma	3.8e-05	0.000342	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—EDN1—asthma	3.77e-05	0.000339	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL5—asthma	3.74e-05	0.000337	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PLA2G4A—asthma	3.72e-05	0.000336	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CSF2—asthma	3.68e-05	0.000332	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—GPCR downstream signaling—IL2—asthma	3.63e-05	0.000327	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SMAD3—asthma	3.58e-05	0.000323	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—CXCL8—asthma	3.45e-05	0.000311	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PPP2CA—asthma	3.43e-05	0.000309	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCR5—asthma	3.37e-05	0.000303	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL2RA—asthma	3.32e-05	0.000299	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL2—asthma	3.29e-05	0.000297	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—C3—asthma	3.29e-05	0.000297	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PDGFB—asthma	3.2e-05	0.000289	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—LEP—asthma	3.06e-05	0.000276	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—FN1—asthma	2.89e-05	0.00026	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—POMC—asthma	2.63e-05	0.000237	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CCL2—asthma	2.58e-05	0.000232	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6R—asthma	2.57e-05	0.000231	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—EGFR—asthma	2.52e-05	0.000227	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—SERPINE1—asthma	2.4e-05	0.000217	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—RHOA—asthma	2.32e-05	0.000209	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—NOS3—asthma	2.3e-05	0.000207	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—CXCL8—asthma	2.04e-05	0.000183	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL2—asthma	1.95e-05	0.000175	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling by GPCR—IL6—asthma	1.94e-05	0.000174	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—MMP9—asthma	1.84e-05	0.000166	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—PTEN—asthma	1.83e-05	0.000165	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—VEGFA—asthma	1.65e-05	0.000149	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—STAT3—asthma	1.64e-05	0.000148	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—TGFB1—asthma	1.52e-05	0.000137	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—EGFR—asthma	1.49e-05	0.000134	CbGpPWpGaD
Azilsartan medoxomil—AGTR1—Signaling Pathways—IL6—asthma	1.14e-05	0.000103	CbGpPWpGaD
